Literature DB >> 18308146

Evolving role of imaging modalities in inflammatory breast cancer.

Carisa H Le-Petross1, Luc Bidaut, Wei T Yang.   

Abstract

Imaging plays several key roles in the diagnosis and assessment of inflammatory breast cancer (IBC). These include characterization of the known tumor, delineation of locoregional disease in the ipsilateral and contralateral breast and regional lymph node basins, diagnosis of distant metastases, and evaluation of treatment response. We review the role of conventional imaging modalities, including mammography and sonography. We also discuss the potential of using evolving imaging modalities such as magnetic resonance imaging (MRI), positron emission tomography with computed tomography (PET/CT), and more advanced or emerging imaging techniques in the assessment of IBC.

Entities:  

Mesh:

Year:  2008        PMID: 18308146     DOI: 10.1053/j.seminoncol.2007.11.016

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  10 in total

1.  Inflammatory breast carcinoma and locally advanced breast carcinoma: characterisation with MR imaging.

Authors:  V Girardi; G Carbognin; L Camera; F Bonetti; E Manfrin; G Pollini; R Pozzi Mucelli
Journal:  Radiol Med       Date:  2010-10-06       Impact factor: 3.469

2.  Ultrasound elastography and magnetic resonance examinations are effective for the accurate diagnosis of mammary duct ectasia.

Authors:  Feixue Zhang; Dexin Yu; Mingming Guo; Qing Wang; Zhigang Yu; Fei Zhou; Meng Zhao; Feng Xue; Guangrui Shao
Journal:  Int J Clin Exp Med       Date:  2015-06-15

3.  An unexpected diagnosis of breast malignancy.

Authors:  T Richardson; F Cottier
Journal:  Ann R Coll Surg Engl       Date:  2017-07       Impact factor: 1.891

Review 4.  Clinical PET-MR Imaging in Breast Cancer and Lung Cancer.

Authors:  Samuel L Rice; Kent P Friedman
Journal:  PET Clin       Date:  2016-10

Review 5.  Current and future applications of magnetic resonance imaging (MRI) to breast and ovarian cancer patient management.

Authors:  Jim Klostergaard; Kenia Parga; Raphael G Raptis
Journal:  P R Health Sci J       Date:  2010-09       Impact factor: 0.705

Review 6.  Approach to inflammatory breast cancer.

Authors:  Andrea Molckovsky; Barbara Fitzgerald; Orit Freedman; Ruth Heisey; Mark Clemons
Journal:  Can Fam Physician       Date:  2009-01       Impact factor: 3.275

7.  ¹⁸F-FDG PET/CT imaging versus dynamic contrast-enhanced CT for staging and prognosis of inflammatory breast cancer.

Authors:  Laurence Champion; Florence Lerebours; Pascal Cherel; Veronique Edeline; Anne-Laure Giraudet; Myriam Wartski; Dominique Bellet; Jean-Louis Alberini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-03       Impact factor: 9.236

8.  Inflammatory breast cancer: time to standardise diagnosis assessment and management, and for the joining of forces to facilitate effective research.

Authors:  D Rea; A Francis; A M Hanby; V Speirs; E Rakha; A Shaaban; S Chan; S Vinnicombe; I O Ellis; S G Martin; L J Jones; F Berditchevski
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

9.  Establishing a program for individuals at high risk for breast cancer.

Authors:  Fernando Cadiz; Henry M Kuerer; Julio Puga; Jamile Camacho; Eduardo Cunill; Banu Arun
Journal:  J Cancer       Date:  2013-07-01       Impact factor: 4.207

10.  Inflammatory breast cancer appearance at presentation is associated with overall survival.

Authors:  Wintana Balema; Diane Liu; Yu Shen; Randa El-Zein; Bisrat G Debeb; Megumi Kai; Beth Overmoyer; Kathy D Miller; Huong T Le-Petross; Naoto T Ueno; Wendy A Woodward
Journal:  Cancer Med       Date:  2021-07-30       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.